India First Heart First

Glenmark Pharmaceuticals Ltd., a global leader in pharmaceuticals, has launched the next phase of their impactful ‘India First Heart First’ campaign, dedicated to raising awareness about cardiovascular diseases (CVD) across India. This initiative, which has garnered widespread support from the medical community, marks a significant advancement in Glenmark’s ongoing efforts to combat heart health challenges in the country.

The campaign’s inaugural phase began with a high-profile event on World Heart Day, September 29, 2023. Renowned artist and Padma Shree recipient Sudarsan Pattnaik created an eye-catching sand sculpture of a human heart at Puri beach, attracting the attention of over 5 million people and significantly boosting awareness about heart health.

Following this success, the campaign has now reached another milestone on World Hypertension Day, May 17, 2024. In collaboration with acclaimed gemstone carver and President’s Award winner Prithviraj Kumawat, Glenmark unveiled an extraordinary human heart sculpture made from a single piece of Rose quartz. This monumental sculpture, standing 8 feet tall and weighing 3.5 tons, symbolizes emotional balance and heart health, aligning with the qualities attributed to the heart chakra.

The unveiling event featured prominent cardiologists from Delhi and Jaipur, such as Dr. Deepak Maheshwari, Dr. J.S. Makkar, and Dr. Manoj Kumar, who spoke on the critical importance of heart health. Esteemed doctors including Dr. J.S. Hiremath, Dr. A Sreenivas Kumar, Dr. JPS Sawhney, and Dr. Dilip Kumar also shared insights into cardiovascular health and prevention strategies. Artist Prithviraj Kumawat discussed his creative process in crafting the Rose quartz sculpture.

A significant highlight of the event was the collective support from 35,000 doctors across India, who pledged their commitment to raising CVD awareness. These signed pledge cards were displayed at the base of the Rose quartz heart sculpture, symbolizing a unified effort to tackle the nation’s cardiovascular health challenges.

Mr. Alok Malik, President and Business Head of India Formulations at Glenmark Pharmaceuticals Ltd., emphasized the broader vision of the campaign, stating, “Through the ‘India First Heart First’ campaign, we are not just raising awareness; we are building a movement. Recognizing the urgent need for greater awareness and proactive health measures, Glenmark is at the forefront of championing heart health. We believe this innovative approach will bring together art, science, and community outreach to create a lasting impact for raising heart health awareness across the country.”

Cardiovascular diseases remain a leading cause of non-communicable disease-related deaths in India, accounting for 17.7 million deaths annually. The World Health Organization reports that India represents one-fifth of global CVD deaths, particularly affecting the younger population. The Global Burden of Disease study highlights an age-standardized CVD death rate of 272 per 100,000 in India, significantly higher than the global average of 235.

With the continued efforts of the ‘India First Heart First’ campaign, Glenmark aims to foster a healthier future for India by driving awareness and encouraging proactive heart health measures nationwide.

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Tags: Glenmark

Related News